Update on the management of von Willebrand disease.
Federici
Augusto B
AB
Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS Foundation Maggiore Policlinico Hospital, University of Milan, Milan, Italy.
D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D004338:Drug Combinations; D005169:Factor VIII / Q000627:therapeutic use*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D014842:von Willebrand Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014841:von Willebrand Factor / Q000627:therapeutic use*
D004338:Drug Combinations; D006490:Hemostatics; C509423:factor VIII, von Willebrand factor drug combination; D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin